India's whole genome sequencing (WGS) of international passengers who tested positive for Covid19 in the last two weeks shows that "XBB" is the most common sub-lineage of the virus among them.
Data released by the Union health ministry on Thursday showed that around 905,647 passengers came to India since December 24, 2022. Around 19,227 samples were tested and around 124 were found to be Covid-19 positive. All the samples that tested positive were sent for WGS, and so far 40 reports have been received.
As many as 14 samples of the 40 were of XBB variant, while BQ1.1, BQ 1.122, BQ 1.1.5 strains were detected in nine samples (see chart).
この記事は Business Standard の January 06, 2023 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Business Standard の January 06, 2023 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
EVALUATING FUND PERFORMANCE Exit a fund only if underperformance persists for 8 quarters
During her annual portfolio review, Mignonne D'Souza (name changed on request), a 44-year-old content writer based in Mumbai, found that four of her seven mutual funds had outperformed, while three lagged behind their benchmarks. D'Souza is wondering if she should stick to these funds or exit them.
Zomato serves up mcap bigger than Tata Motors, Bajaj
Stock could be a 'potential doubler in three to four years'
'PARRVA' introduced for verification of risk-return metrics
In a bid to clamp down on individuals and entities making lofty return claims, the Securities and Exchange Board of India (Sebi) has introduced a \"Past Risk and Return Verification Agency\" (PaRRVA), which will be tasked to verify the risk-return metrics of services offered by investment advisors, research analysts (RAS), algorithmic trading platforms, and other such entities.
Regulator brings in new rule to address NFO mis-selling
The Securities and Exchange Board of India (Sebi) has introduced a new rule aimed at putting a stop to unnecessary portfolio churn by distributors to pocket higher commissions, amid rising asset mobilisation through the new fund offer (NFO) route.
Core acquisition adds to Metropolis' long-term growth plans
Metropolis Healthcare (MHL) has decided to acquire a 100 per cent stake in Gurgaon-based Core Diagnostics for ₹247 crore.
Euro Pratik eyes ₹700-1,000 cr public offer
Euro Pratik, a prominent player in the decorative wall panel industry, is set to file draft papers with the Securities and Exchange Board of India (Sebi) for an initial public offering (IPO) worth ₹700-1,000 crore, sources familiar with the matter said on Thursday.
Nifty may trade in 25K-28K range in 2025: Smallcase
The benchmark Nifty50 index may move in the range 25,000-28,000 next year, according to a survey conducted by Smallcase of 150 managers on its investment platform. The Nifty on Thursday closed at 23,951.
IKS Health surges 48% on debut
BOOSTER DOSE
Moderate return expectations for '25: HDFC Securities
Domestic brokerage HDFC Securities has told investors to moderate return expectations amidst elevated valuations.
Expensive valuations to keep mkts volatile
Domestic equities have seen selloff this week amid weakening rupee
